Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-12
2009-08-11
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S578000
Reexamination Certificate
active
07572784
ABSTRACT:
This invention relates to compounds and methods for the treatment of cancer. In particular, the invention provides compounds that inhibit Aurora kinase, pharmaceutical compositions comprising the compounds, and methods of using the compounds for the treatment of cancer.
REFERENCES:
patent: 4099012 (1978-07-01), Gschwend
patent: 4469633 (1984-09-01), Trybulski
patent: 4481142 (1984-11-01), Fryer et al.
patent: 5166151 (1992-11-01), Freidinger et al.
patent: 5210082 (1993-05-01), Bock et al.
patent: 6057329 (2000-05-01), Davis et al.
patent: 6277844 (2001-08-01), Spector
patent: 2003/0022885 (2003-01-01), Bebbington et al.
patent: 2003/0055068 (2003-03-01), Bebbington et al.
patent: 0 014 470 (1985-07-01), None
patent: 0 273 697 (1988-07-01), None
patent: WO 00/67754 (2000-11-01), None
patent: WO 03/013545 (2003-02-01), None
patent: WO 2005/037843 (2005-04-01), None
patent: WO 2006/070198 (2006-07-01), None
Search Report and Written Opinion of the International Searching Authority in International Application No. PCT/US2005/016445, WO2005/111039, which corresponds to U.S. Appl. No. 11/127,855, Jul. 12, 2005.
Meraldi, Patrick, et al., “Aurora-A Overexpression Reveals Tetraploidization as a Major Route to Centrosome Amplification in p53−/−Cells,”The EMBO Journal, vol. 21, No. 4, pp. 438-492 (2002).
Harrington, Elizabeth A., et al., “VX-680, A Potent and Selective Small-Molecule Inhibitor of the Aurora Kinases, Suppresses Tumor Growth In Vivo,”Nature Medicine, pp. 1-6 (Feb. 22, 2004), www.nature.com.
Ditchfield, Claire, et al., “Aurora B Couples Chromosome Alignment With Anaphase by Targeting BubR1, Mad2, and Cenp-E to Kinetochores,”The Journal of Cell Biology, vol. 161, No. 2, pp. 267-280 (Apr. 28, 2003).
Sausville, Edward A., “Aurora Kinases Dawn as Cancer Drug Targets,”Nature Medicine, vol. 10, No. 3, pp. 234-235 (Mar. 2004).
Silke, Hauf, et al., “The Small Molecule Hesperadin Reveals a Role for Aurora B in Correcting Kinetochore-Microtubule Attachment and in Maintaining the Spindle Assembly Checkpoint,”The Journal of Cell Biology, vol. 161, No. 2, pp. 281-294 (Apr. 28, 2003).
Bischoff, James R. et al., “A Homologue of Drosophila Aurora Kinase is Oncogenic and Amplified in Human Colorectal Cancers,”The EMBO Journal, vol. 17, No. 11, pp. 3052-3065 (1998).
Zhou, Hongyi, et al., “Tumour Amplified Kinase STK15/BTAK Induces Centrosome Amplification, Aneuploidy and Transformation,”Nature Genetics, vol. 20, pp. 189-193 (Oct. 1998).
Xia, Wenle, et al., “Tumor Selective G2/M Cell Cycle Arrest and Apoptosis of Epithelial and Hematological Malignancies by BBL22, a Benzazepine,”Proc. Natl. Acad. Sci. USA, vol. 97, No. 13, pp. 7494-7499 (Jun. 20, 2000).
Wang, James K.T., et al., “Benzodiazepines that Bind at Peripheral Sites Inhibit Cell Proliferation,”Proc. Nat. Acad. Sci. USA, vol. 81, pp. 753-756 (Feb. 1984).
Cantor, E.H., et al., “Interaction of Calcium Channel Blockers with Non-Neuronal Benzodiazepine Binding Sites,”Proc. Natl. Acad. Sci. USA, vol. 81, pp. 1549-1552 (Mar. 1984).
Solowey, W.E. et al., “Peripheral-Acting Benzodiazepines Inhibit the Growth of Human Melanoma Cells and Potentiate the Antiproliferative Activity of Recombinant Human Interferons,”The Journal of Interferon Research, vol. 10, No. 3, pp. 269-280 (Jun. 1990).
Vankayalapati, Hariprasad, et al., “Targeting Aurora2 Kinase in Oncogenesis: A Structural Bioinformatics Approach to Target Validation and Rational Drug Design,”Molecular Cancer Therapeutics, vol. 2, pp. 283-294 (Mar. 2003).
Carmena, Mar, et al., “The Cellular Geography of Aurora Kinases,”Nature, vol. 4, pp. 842-854 (Nov. 2003).
Boyce Richard J.
Claiborne Christopher F.
Payne Lloyd J.
Sells Todd B.
Stroud Stephen G.
Coleman Brenda L
Millennium Pharmaceuticals Inc.
LandOfFree
Compounds and methods for inhibiting mitotic progression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for inhibiting mitotic progression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for inhibiting mitotic progression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4107614